$87.45
+1.89
(+2.21%)
As of Oct 21, 2026, 6:56 AM EDT
Price history
Today's analyst average
Analyst average over timeIndividual analyst targets
Analyst history starts Jul 28, 2026, the first target we tracked for CLX.
Key facts
- 52-week range (closes)
- $80.41 – $127.16 Lowest close Oct 2, 2026, highest Feb 27, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
- Fiscal year ends
- June Fiscal 2025 ended Jun 30, 2025, from SEC filings
- In the S&P 500 since
- Mar 31, 1969 · All S&P 500 changes
Clorox (CLX) is trading up at $87.45 (+2.21%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Staples sector.
Analyst price targets on CLX
Current price targets from 2 firms average $102, ranging from $98 to $105 — 16% above the current $87.5. Each is tracked to its date and scored the same way a member's call is.
- UBS $105 → $105 by Aug 2027 Aug 4, 2026 via Investing.com · UBS's track record
- Jefferies $100 → $98 by Jul 2027 Jul 28, 2026 via Investing.com · Jefferies's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Clorox revenue & net income history (FY2016–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2016Jun 2016 | FY2017Jun 2017 | FY2018Jun 2018 | FY2019Jun 2019 | FY2020Jun 2020 | FY2021Jun 2021 | FY2022Jun 2022 | FY2023Jun 2023 | FY2024Jun 2024 | FY2025Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.76B | $5.97B | $6.12B | $6.21B | $6.72B | $7.34B | $7.11B | $7.39B | $7.09B | $7.10B |
| Growth (year over year) | +1.9% | +3.7% | +2.5% | +1.5% | +8.2% | +9.2% | −3.2% | +4.0% | −4.0% | +0.2% |
| Gross profit | $2.60B | $2.67B | $2.67B | $2.73B | $3.06B | $3.20B | $2.54B | $2.91B | $3.05B | $3.21B |
| Gross margin | 45.1% | 44.7% | 43.7% | 43.9% | 45.6% | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% |
| Net income | $648.0M | $701.0M | $823.0M | $820.0M | $939.0M | $710.0M | $462.0M | $149.0M | $280.0M | $810.0M |
| Net margin | 11.2% | 11.7% | 13.4% | 13.2% | 14.0% | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% |
| EPS (diluted) | $4.92 | $5.33 | $6.26 | $6.32 | $7.36 | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 |
| Balance sheet | ||||||||||
| Cash and equivalents | $401.0M | $418.0M | $131.0M | $111.0M | $871.0M | $319.0M | $183.0M | $367.0M | $202.0M | $167.0M |
| Total assets | $4.51B | $4.57B | $5.06B | $5.12B | $6.21B | $6.33B | $6.16B | $5.95B | $5.75B | $5.56B |
| Total liabilities | $4.21B | $4.03B | $4.33B | $4.56B | $5.30B | $5.74B | $5.43B | $5.56B | $5.26B | $5.08B |
| Long-term debt | $1.79B | $1.39B | $2.28B | $2.29B | $2.78B | $2.48B | $2.47B | $2.48B | $2.48B | $2.48B |
| Shareholders' equity | $297.0M | $542.0M | $726.0M | $559.0M | $908.0M | $411.0M | $556.0M | $220.0M | $328.0M | $321.0M |
| Cash flow | ||||||||||
| Operating cash flow | $778.0M | $865.0M | $976.0M | $992.0M | $1.55B | $1.28B | $786.0M | $1.16B | $695.0M | $981.0M |
| Capital expenditure | $172.0M | $231.0M | $194.0M | $206.0M | $254.0M | $331.0M | $251.0M | $228.0M | $212.0M | $220.0M |
| Free cash flow | $606.0M | $634.0M | $782.0M | $786.0M | $1.29B | $945.0M | $535.0M | $930.0M | $483.0M | $761.0M |
| Dividends paid | $398.0M | $412.0M | $450.0M | $490.0M | $533.0M | $558.0M | $571.0M | $583.0M | $595.0M | $602.0M |
| Share buybacks | $254.0M | $183.0M | $271.0M | $661.0M | $248.0M | $905.0M | $25.0M | $0 | $0 | $332.0M |
RevenueNet incomeNet margin (right axis, %)
| Q4 FY24†Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25†Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.90B | $1.76B | $1.69B | $1.67B | $1.99B | $1.43B | $1.67B | $1.67B |
| Growth (year over year) | −5.7% | +27.1% | −15.3% | −8.0% | +4.5% | −18.9% | −0.8% | +0.1% |
| Gross profit | $884.0M | $807.0M | $738.0M | $744.0M | $924.0M | $596.0M | $722.0M | $722.0M |
| Gross margin | 46.5% | 45.8% | 43.8% | 44.6% | 46.5% | 41.7% | 43.2% | 43.2% |
| Net income | $216.0M | $99.0M | $193.0M | $186.0M | $332.0M | $80.0M | $157.0M | $187.0M |
| Net margin | 11.4% | 5.6% | 11.4% | 11.2% | 16.7% | 5.6% | 9.4% | 11.2% |
| EPS (diluted) | $1.74 | $0.80 | $1.54 | $1.50 | $2.68 | $0.65 | $1.29 | $1.54 |
| Balance sheet | ||||||||
| Cash and equivalents | $202.0M | $278.0M | $290.0M | $226.0M | $167.0M | $166.0M | $227.0M | $1.19B |
| Total assets | $5.75B | $5.50B | $5.58B | $5.51B | $5.56B | $5.53B | $5.61B | $6.44B |
| Total liabilities | $5.26B | $5.27B | $5.46B | $5.32B | $5.08B | $5.39B | $5.58B | $6.34B |
| Long-term debt | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.49B | $2.49B |
| Shareholders' equity | $328.0M | $60.0M | −$41.0M | $27.0M | $321.0M | −$22.0M | −$125.0M | −$67.0M |
| Cash flow | ||||||||
| Operating cash flow | $340.0M | $221.0M | $180.0M | $286.0M | $294.0M | $93.0M | $311.0M | −$122.0M |
| Capital expenditure | $81.0M | $39.0M | $53.0M | $53.0M | $75.0M | $36.0M | $42.0M | $43.0M |
| Free cash flow | $259.0M | $182.0M | $127.0M | $233.0M | $219.0M | $57.0M | $269.0M | −$165.0M |
| Dividends paid | $149.0M | $151.0M | $151.0M | $150.0M | $150.0M | $151.0M | $151.0M | $150.0M |
| Share buybacks | $0 | $107.0M | $150.0M | $0 | $75.0M | $129.0M | $127.0M | $0 |
From Clorox's 10-K and 10-Q filings with the SEC; its fiscal year ends in June. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Clorox
The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.
- Headquarters
- Oakland, California From SEC filings, Oct 2026
Recent News (20)
-
Clorox Announces November 2 Webcast of First-Quarter Fiscal Year 2027 Results OAKLAND, Calif., Oct. 12, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its first-quarter fiscal year 2027 results on November 2, 2026. Timing for the announcement will be as follows:…
-
The Clorox Company Announces the Official Launch of Clorox Purell ProCare™ The new B2B-focused business, created through the combination of CloroxPro and GOJO, Makers of Purell, brings professional and healthcare customers unparalleled access to the most trusted health and h…
-
Clorox stock hits 52-week low at 82.47 USD
Clorox stock hits 52-week low at 82.47 USD
-
Clorox Declares Regular Quarterly Dividend of $1.25 Per Share OAKLAND, Calif., Sept. 23, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.25 per share on the company's common …
-
Clorox vs. Kimberly-Clark: Which Household Staples Dividend Is Safer
Clorox vs. Kimberly-Clark: Which Household Staples Dividend Is Safer
-
Clorox stock hits 52-week low at 84.69 USD
Clorox stock hits 52-week low at 84.69 USD
-
Clorox at Boston Global Staples Conference 2026: growth plan in focus
Clorox at Boston Global Staples Conference 2026: growth plan in focus
-
CPSC Posts Product Recalls and Product Safety Warnings to its Web Site WASHINGTON, Sept. 3, 2026 /PRNewswire/ -- The CPSC announces today the following product recalls and product safety warnings are posted and can be viewed at www.cpsc.gov. Clorox Puerto Rico Recalls 6 …
-
Consumer staples short interest: Clorox tops list, Walmart at the bottom (KO:NYSE) Consumer staples short interest: Clorox tops list, Walmart at the bottom (KO:NYSE) Seeking Alpha
-
-
Hidden Valley Ranch dressing may be a victim of this summer’s salad scare As the cyclospora outbreak has made consumers more cautious about salad purchases, one analyst points to sales declines for Clorox’s Hidden Valley brand.
-
Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX)
Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX)
-
Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?
Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?
-
Clorox (CLX) Q4 2026 Earnings Call Transcript Clorox (CLX) Q4 2026 Earnings Call Transcript
-
DUDE Wipes Appoints Steve Winchell as First-Ever Chief Product DUDE, Marking Company's First C-Suite Executive Hire Since Founding Former Honest Company, Clorox and Burt's Bees executive joins DUDE Wipes following company's milestone of surpassing $1 billion in lifetime sales CHICAGO, Aug. 11, 2026 /PRNewswire/ -- DUDE Wipes, the…
-
-
UBS raises Clorox stock price target to $105 on achievable outlook
UBS raises Clorox stock price target to $105 on achievable outlook
-
Clorox fiscal 2027 outlook: inflation and value shoppers weigh Clorox fiscal 2027 outlook: inflation and value shoppers weigh
-
The Clorox Company Q4 2026 Earnings Call Summary The Clorox Company Q4 2026 Earnings Call Summary
-
Clorox Projects Tough Fiscal Year with Inflation, Value-Seeking Customers Clorox Projects Tough Fiscal Year with Inflation, Value-Seeking Customers
More Consumer Staples stocks
- CASY Casey's
- CCEP Coca-Cola Europacific Partners
- CHD Church & Dwight
- CL Colgate-Palmolive
- COST Costco
- DG Dollar General
- DLTR Dollar Tree
- EL Estée Lauder Companies (The)